Location History:
- Sneinton, GB (2013)
- Nottingham, GB (2015 - 2024)
Company Filing History:
3 out of 846 
2 out of 2 
2 out of 3 
Years Active: 2013-2025
Title: The Innovative Mind of David Cousin
Introduction: David Cousin, a talented inventor hailing from Nottingham, GB, has made significant contributions to the field of pharmaceuticals through his inventive spirit and dedication to scientific advancements.
Latest Patents:
1. Benzolactam compounds as protein kinase inhibitors: David's invention provides a compound of formula (0) that serves as an inhibitor of ERK1/2 kinases. This innovation holds promise in the treatment of ERK1/2-mediated conditions, particularly in the realm of cancer therapy.
2. Aminothiazole compounds as inhibitors of CTPS1: Through the development of compounds of formula (I) and related aspects, David has introduced a novel class of inhibitors. These compounds have the potential to revolutionize treatment strategies for various conditions.
Career Highlights: David Cousin has amassed an impressive portfolio with 8 patents to his name. Notably, he has lent his expertise to renowned companies such as Otsuka Pharmaceutical Company, Limited and Pharminox Limited, where his inventive prowess has shone through.
Collaborations: Throughout his illustrious career, David has collaborated with esteemed professionals in the field. Some of his notable coworkers include Stuart Thomas Onions and Charlotte Mary Griffiths-Jones, who have contributed to the success of joint projects.
Conclusion: David Cousin's ingenuity and relentless pursuit of innovation have solidified his position as a trailblazer in the realm of pharmaceutical inventions. His groundbreaking patents and collaborative efforts underscore his invaluable contributions to the scientific community, shaping the landscape of modern medicine.